Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$34.28
+1.6%
$33.19
$28.34
$43.99
$17.55B0.64.38 million shs1.78 million shs
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$228.55
+0.5%
$231.83
$218.75
$251.99
$65.67B0.351.61 million shs928,650 shs
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$72.50
+2.2%
$71.49
$58.93
$95.73
$42.64B1.124.80 million shs2.77 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$419.28
+0.8%
$437.07
$398.50
$548.88
$34.01B1.39581,262 shs384,499 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
0.00%+1.63%-2.16%+17.90%-21.02%
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.00%-1.43%+0.79%+0.37%-8.13%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
0.00%+0.63%-1.00%-4.50%-25.81%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.00%-1.22%-4.86%+0.76%-22.98%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Baxter International Inc. stock logo
BAX
Baxter International
4.437 of 5 stars
2.25.01.74.01.51.72.5
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
4.7444 of 5 stars
2.54.04.24.03.03.31.3
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
4.6163 of 5 stars
3.23.00.04.03.02.52.5
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
4.2486 of 5 stars
3.42.00.03.73.12.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
2.40
Hold$38.5612.49% Upside
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
3.00
Buy$278.2921.76% Upside
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
2.40
Hold$79.9510.28% Upside
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.80
Moderate Buy$533.7527.30% Upside

Current Analyst Ratings Breakdown

Latest BAX, BDX, EW, and IDXX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/10/2025
Baxter International Inc. stock logo
BAX
Baxter International
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$39.00 ➝ $41.00
2/26/2025
Baxter International Inc. stock logo
BAX
Baxter International
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold ➝ Buy$42.00
2/24/2025
Baxter International Inc. stock logo
BAX
Baxter International
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
2/21/2025
Baxter International Inc. stock logo
BAX
Baxter International
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$38.00 ➝ $36.00
2/20/2025
Baxter International Inc. stock logo
BAX
Baxter International
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$39.00
2/14/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$278.00 ➝ $279.00
2/13/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$88.00 ➝ $90.00
2/13/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$68.00 ➝ $71.00
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Strong Sell
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$85.00 ➝ $85.00
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$70.00 ➝ $73.00
(Data available from 3/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$10.64B1.65$5.31 per share6.45$16.69 per share2.05
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$20.64B3.18$21.24 per share10.76$89.57 per share2.55
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$5.44B7.84$2.68 per share27.04$11.08 per share6.54
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.90B8.72$10.50 per share39.92$19.48 per share21.52
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
-$649M-$1.28N/A12.550.93-5.05%16.67%4.93%5/1/2025 (Estimated)
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.71B$6.0237.9914.611.638.47%15.74%7.29%5/1/2025 (Estimated)
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$4.17B$6.9710.4126.364.8272.93%19.40%14.37%4/24/2025 (Estimated)
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$887.87M$10.6739.3330.873.4122.78%55.82%26.48%5/7/2025 (Estimated)

Latest BAX, BDX, EW, and IDXX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2025N/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.60N/AN/AN/A$1.40 billionN/A
2/20/2025Q4 2024
Baxter International Inc. stock logo
BAX
Baxter International
$0.52$0.58+$0.06-$1.00$2.67 billion$2.75 billion
2/11/2025Q4 2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.55$0.59+$0.04$0.65$1.36 billionN/A
2/5/2025Q1 2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.00$3.43+$0.43$1.04$5.13 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$0.681.98%-1.40%N/A N/A
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.161.82%+5.00%69.10%53 Years
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A

Latest BAX, BDX, EW, and IDXX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/11/2025
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.172.22%2/28/20252/28/20254/1/2025
1/28/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.041.67%3/10/20253/10/20253/31/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.31
1.43
1.09
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.69
1.13
0.63
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
0.06
3.46
2.89
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.28
1.31
0.95

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
86.97%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
79.46%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%
CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
60,000511.63 million509.47 millionOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
74,000287.14 million286.10 millionOptionable
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
17,300587.90 million582.19 millionOptionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
10,80081.06 million80.16 millionOptionable

Recent News About These Companies

Stifel Nicolaus Keeps Their Hold Rating on Idexx Laboratories (IDXX)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Baxter International stock logo

Baxter International NYSE:BAX

$34.28 +0.53 (+1.56%)
As of 03:10 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$228.55 +1.05 (+0.46%)
As of 03:10 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$72.50 +1.59 (+2.24%)
As of 03:10 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

IDEXX Laboratories stock logo

IDEXX Laboratories NASDAQ:IDXX

$419.28 +3.41 (+0.82%)
As of 03:10 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.